Cancer

Titlesort descending Average Rating
Newcastle disease virus as an oncolytic agent. 80.00%
NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell 90.00%
Novel anti-angiogenic therapies for malignant gliomas. 50.00%
Novel dammarane-type sapogenins from Panax ginseng berry and their biological activities. 70.00%
NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial 85.00%
Nuts and green tea key to cancer treatment? 60.00%
Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. 90.00%
Oireachtas Special Committee on COVID-19 Response 70.00%
Oleic Acid, deglycosylated vitamin D-binding protein, nitric oxide: a molecular triad made lethal to cancer. 100.00%
Oncologic benefit of tonsillectomy in stage I and II tonsil cancer: a surveillance epidemiology and end results database review 70.00%
Oncolytic virus therapy for malignant brain tumors 60.00%
Oncolytic virus therapy for prostate cancer. 70.00%
Oncolytic Virus Treatment 70.00%
Open Source Cancer Resaearch - A video 90.00%
Opioid growth factor and the treatment of human pancreatic cancer: a review. 90.00%
Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell c 80.00%
Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancer. 55.00%
Optimizing a novel regional chemotherapeutic agent against melanoma: hyperthermia-induced enhancement of temozolomide cytot..... 80.00%
Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study. 60.00%
Oral metronomic chemotherapy using cyclophosphamide in metastatic patients (pts) after standard treatment: Results of a randomiz 25.00%
Oral metronomic cyclophosphamide in elderly with metastatic melanoma. 70.00%
Outpatient administration of high-dose methotrexate for osteosarcoma treatment in Brazil. 30.00%
Outside the box--novel therapeutic strategies for glioblastoma. 80.00%
Pancreatic cancer stem cells - insights and perspectives. 40.00%
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities 50.00%
Pharmacology and safety factors affecting use of flat (rather than weight-based) dosing of tesetaxel, an orally administered.... 30.00%
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the 30.00%
Phase I adjuvant trial of multi-epitope p53 vaccine for patients with squamous cell carcinoma of the head and neck (SCCHN): A pr 45.00%
Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. 70.00%
Phase I study of sunitinib malate continuously dosed and standard-infusion gemcitabine in solid tumors. 70.00%
Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer. 80.00%
Phase II study of docetaxel-prednisone (DP) in combination with metronomic cyclophosphamide (CTX) and celecoxib (C) ...... 95.00%
Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults. 40.00%
Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer 80.00%
Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer 70.00%
Phase II trial of pharmacodynamically (PDally)-guided optimal biologic dose titration (OBDT) of sorafenib (S) in combination wit 70.00%
Photodynamic Therapy 70.00%
Pilot study of a specific dietary supplement in tumor-bearing mice and in stage IIIB and IV non-small cell lung cancer patients. 80.00%
Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. 70.00%
Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer. 90.00%
Possible association between nanobacteria and malignant microcalcifications in breast cancer. 80.00%
Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. 50.00%
Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma 80.00%
PPAR gamma agonists can be expected to potentiate the efficacy of metronomic chemotherapy through CD36 up-regulation. 70.00%
Pre-Clinical Investigations on Ukrain 90.00%
Preclinical antitumor and antiangiogenic activity of a metronomic schedule of cisplatin against human transitional cell carcinom 50.00%
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer. 50.00%
Preliminary pharmacokinetic studies of Ukrain in rats
Preliminary studies on the effect of Ukrain on the immunological response in patients with malignant tumours. 60.00%
Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization. 80.00%
Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway. 80.00%
Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment.
Programmed drug delivery: nanosystems for tumor targeting. 60.00%
Propolis Extract (Bio 30) Suppresses the Growth of Human Neurofibromatosis (NF) Tumor Xenografts in Mice 55.00%
Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador) 80.00%
Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador). 90.00%
Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age.
Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. 70.00%
Proton Therapy 70.00%
PSMA - Lutetium Treatment
Psorinum therapy in treating stomach, gall bladder, pancreatic, and liver cancers: a prospective clinical study. 100.00%
Psorinum, the anti cancer miracle from India. 91.47%
Psychodynamic psychotherapy, therapeutic touch and cancer. A review of the method of intervention and studv of 75 cases 100.00%
Pycnogenol may alleviate adverse effects in oncologic treatment. 60.00%
Quality of radiosurgery for single brain metastases with respect to treatment technology: a matched-pair analysis. 70.00%
Radiofrequency ablation 70.00%
Radiomodification effects of Ukrain, a cytostatic and immunomodulating drug, on intracellular glucocorticoid reception during sh 60.00%
Radiosurgery for spinal malignant tumors. 70.00%
Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus u 50.00%
Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer. 70.00%
Randomized phase II trial of capecitabine versus capecitabine, low molecular weight heparin, and prednisone in refractory....... 70.00%
Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119 70.00%
Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer. 40.00%
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative.. 80.00%
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative....
RECURRENCE OF BRAIN TUMORS MAY BE PREVENTED WITH RUTA AND CALCAREA PHOSPHORICA 90.00%
Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract. 95.00%
Regional hyperthermia in high-risk soft tissue sarcomas. 80.00%
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory 80.00%
Removed because of suspicion of scientific fraud: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF. 10.00%
Removed from Pubmed because of suspicion of scientific fraud: Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). 55.00%
Removed from Pubmed because of suspiion of scientific fraud: Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF. 75.00%
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status 60.00%
Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced 90.00%
Response of brain metastases from breast cancer to megestrol acetate: a case report. 80.00%
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer 60.00%
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer. 40.00%
Results of Ukrain monotherapy of prostate cancer 50.00%
Resveratrol 80.00%
Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR. 50.00%
Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors 90.00%
Reversal of Signs and Symptoms of a B-Cell Lymphoma in a Patient Using Only Low-Dose Naltrexone 100.00%
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo 70.00%
Review on molecular and therapeutic potential of thymoquinone in cancer. 60.00%
Review. Current role and future perspectives of hyperthermia for prostate cancer treatment. 60.00%
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic ca 90.00%
Role of everolimus in the treatment of renal cell carcinoma. 50.00%
Role of infectious agents in the emergence of malignant tumors 90.00%
Roles of sildenafil in enhancing drug sensitivity in cancer. 50.00%
ROS production and angiogenic regulation by macrophages in response to heat therapy. 80.00%

Pages